1Holland CK,Vaidya SS,Datta S,et al.Ultrasound-enhanced tissueplasminogen activator thrombolysis in an invitro porcine clotmodel[J].Thromb Res,2008,121(5):663-673.
2Shaw GJ,Bavani N,Dhamija A,et al.Effect of mild hypothermiaon the thrombolytic efficacy of 120 kHz ultrasound enhancedthrombolysis in an in-vitro human clot model[J].Thromb Res,2006,117(5):603-608.
3Meretoja A,Tatlisumak T.Thrombolytic therapy in acute ischemicstroke-basic concepts[J].Curr Vasc Pharmacol,2006,4(1):31-44.
4Esmon CT.Basic mechanisms and pathogenesis of venousthrombosis[J].Blood Rev,2009,23(5):225-229.
5Krueger K,Deissler P,Coburger S,et al.How thrombus modelimpacts the in vitro study of interventional thrombectomyprocedures[J].Invest Radiol,2004,39(10):641-648.
8Kirchhof K,Welzel T,Zoubaa S,et al.New method of emboluspreparation for standardized embolic stroke in rabbits[J].Stroke,2002,33(9):2329-2333.
9Grimm J,Jahnke T,Muhle C,et al.Influence of thrombus age on themechanical thrombectomy efficacy of the amplatz thrombectomydevice in vitro[J].Cardiovasc Intervent Radiol,2003,26(3):265-268.
10Grimm J,Müller-Hülsbeck S,Heller M.Comparison of themechanical thrombectomy efficacy of the amplatz thrombectomydevice and the cragg thrombolytic brush in vitro[J].Invest Radiol,2001,36(4):204-209.
8Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet trans-plantation? [ J]. Diabetes,1999, 48 (10) : 1907-1914.
9Soland MA, Bego M, Colletti E, et al. Mesenehymal stem cells engineered to inhibit complement-mediated damage [J]. PLoS One, 2013, 8(3) :e60461.
10Eriksson O, Eich T, Sundin A, et al. Positron emission tomography in clinical islet transplantation [ J ]. Am J Transplantation, 2009, 9( 12) :2816-2824.
